Bristol-Myers, Gilead, and Biogen hike US drug prices as the new year begins – CNBC

Share this Story

Drugmakers including Bristol-Myers Squibb, Gilead Sciences, and Biogen hiked U.S. list prices on more than 50 drugs on Wednesday.

Author: Reuters

READ MORE